FOXA1 and posterior cortical atrophy: According to tissue microarray (TMA) data, patients classified with stage II PCa (localized tumor with medium to low PSA levels) had comparable SKP2:FOXA1 ratios to normal prostate, indicating similar protein levels and no significant differences in abundance.